How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir

How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir

Bibliographic Details
Main Authors:	Atze T. Das, Ben Berkhout, Dimitrios Paraskevis
Format:	Article
Language:	English
Published:	American Society for Microbiology 2018-04-01
Series:	mBio
Online Access:	http://mbio.asm.org/cgi/content/full/9/2/e00006-18

Similar Items

Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
by: Isabelle Malet, et al.
Published: (2018-05-01)

Variability in HIV-1 Integrase Gene and 3′-Polypurine Tract Sequences in Cameroon Clinical Isolates, and Implications for Integrase Inhibitors Efficacy
by: Arpan Acharya, et al.
Published: (2020-02-01)

7-step flow synthesis of the HIV integrase inhibitor Dolutegravir
by: Ziegler, Robert E., et al.
Published: (2020)

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
by: Isabelle Malet, et al.
Published: (2017-09-01)

Dolutegravir interactions with HIV-1 integrase-DNA: structural rationale for drug resistance and dissociation kinetics.
by: Felix DeAnda, et al.
Published: (2013-01-01)

SiRNA-induced mutation in HIV-1 polypurine tract region and its influence on viral fitness.
by: Jason W Rausch, et al.
Published: (2015-01-01)

The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome.
by: Nikki van Bel, et al.
Published: (2014-01-01)

Similarity of Chemokines Charge and the V3 Domain of HIV-1 env Protein
by: Ben Berkhout, et al.
Published: (1998-06-01)

HIV-1 Escape From RNAi Antivirals: Yet Another Houdini Action?
by: Ben Berkhout, et al.
Published: (2012-01-01)

Evaluation and Prediction of the HIV-1 Central Polypurine Tract Influence on Foamy Viral Vectors to Transduce Dividing and Growth-Arrested Cells
by: Sergey Shityakov, et al.
Published: (2014-01-01)

Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS
by: Taha H, et al.
Published: (2015-10-01)

Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding.
by: Rumbidzai Chitongo, et al.
Published: (2020-01-01)

Relationship between HIV integrase polymorphisms and integrase inhibitor susceptibility: An in silico analysis
by: Hotma Martogi Lorensi Hutapea, et al.
Published: (2018-12-01)

Correction: Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding.
by: Rumbidzai Chitongo, et al.
Published: (2020-01-01)

HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol
by: Ezechiel Ngoufack Jagni Semengue, et al.
Published: (2020-04-01)

Opening of the TAR hairpin in the HIV-1 genome causes aberrant RNA dimerization and packaging
by: Das Atze T, et al.
Published: (2012-07-01)

The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011)

The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011)

The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase
by: Ni, Xiaoju
Published: (2011)

CRISPR-Cas9 Dual-gRNA Attack Causes Mutation, Excision and Inversion of the HIV-1 Proviral DNA
by: Caroline S. Binda, et al.
Published: (2020-03-01)

HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study
by: Murrell, Derek E., et al.
Published: (2019)

Patterns of resistance development with integrase inhibitors in HIV
by: Jean L Mbisa, et al.
Published: (2011-02-01)

Raltegravir: first in class HIV integrase inhibitor
by: Zelalem Temesgen, et al.
Published: (2008-06-01)

Synthesis of Potential HIV-1 Integrase Inhibitors
by: Chi-Tsan Liu, et al.
Published: (2001)

HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play?
by: Vogel Martin, et al.
Published: (2009-11-01)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01)

HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.
by: Geoffrey S Gottlieb, et al.
Published: (2011-01-01)

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors
by: Rossana Scutari, et al.
Published: (2020-03-01)

Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies
by: Gilles Darcis, et al.
Published: (2018-03-01)

Deep sequencing of small TAR-derived RNAs in HIV-1 producing cells
by: Harwig Alex, et al.
Published: (2011-10-01)

The role of dolutegravir in the management of HIV infections
by: Miller MM, et al.
Published: (2015-02-01)

DOLUTEGRAVIR efficacy in HIV infected patients
by: Dumitru Irina Magdalena, et al.
Published: (2015-02-01)

Viral reverse transcriptases show selective high affinity binding to DNA-DNA primer-templates that resemble the polypurine tract.
by: Gauri R Nair, et al.
Published: (2012-01-01)

Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.
by: Kushol Gupta, et al.
Published: (2016-12-01)

Inhibitors of HIV-1 integrase from Dioscorea bulbifera
by: Prapaporn Chaniad, et al.
Published: (2016-06-01)

Mechanism of action of allosteric HIV-1 integrase inhibitors
by: Slaughter, Alison Paige
Published: (2015)

The viral Tat protein has no essential function in HIV-1 replication other than to activate transcription
by: Berkhout Ben, et al.
Published: (2009-09-01)

A Phylogenetic Survey on the Structure of the HIV-1 Leader RNA Domain That Encodes the Splice Donor Signal
by: Nancy Mueller, et al.
Published: (2016-07-01)

On the generation of the MSD-Ѱ class of defective HIV proviruses
by: Atze T. Das, et al.
Published: (2019-07-01)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
by: Karolin Meixenberger, et al.
Published: (2017-11-01)

Cannot write session to /tmp/vufind_sessions/sess_1nadocadrss2cn93hvgl4urp1b